What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.
Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.
Ingredients: CMR substances; Trimethylbenzoyl Diphenylphosphine Oxide (TPO)
Date of publication: 13 May 2025
The EU officially bans new CMR substances in cosmetics through Regulation 2025/877, applicable from 1 September 2025, including Trimethylbenzoyl Diphenylphosphine Oxide used in artificial nail systems.
Ingredient: Benzophenone-1
Date of publication: 01/04/2025
The SCCS concluded that Benzophenone-1 is not safe when used as a light stabilizer in cosmetic products due to genotoxicity potential and endocrine disrupting properties.
Ingredient: Salicylic Acid
Date of publication: 30 april 2025
The SCCS concluded that Salicylic Acid at 0.5% is not safe for children aged 3-10 years when used in combination, establishing new limits: 0.5% in rinse-off products, 0.15% in leave-on products, and 0.1% in oral care products.
Ingredient: Butylparaben
Date of publication: 30/04/2025
The SCCS concluded that Butylparaben at 0.14% is not safe for children when used in combination, establishing new limits: 0.14% in rinse-off products, 0.002% in leave-on products, and 0.092% in oral care products.
Ingredients: Melaleuca Alternifolia Leaf Oil
Date of publication: 6 june 2025
On June 6 2025, the SCCS has published a preliminary Scientific Opinion establishing specific concentration limits for Tea Tree Oil in cosmetic products, allowing its continued use as an anti-seborrheic and anti-microbial agent despite pending CMR 1B classification under CLP Regulation.
Ingredients: Benzophenone-2 and Benzophenone-5
Date of publication: 22 april 2025
The SCCS has concluded that Benzophenone-2 may pose consumer risk due to genotoxicity and endocrine activity concerns, while Benzophenone-5 is considered safe up to 5% in specified UV filter applications based on read-across data from Benzophenone-4.
Ingredients: Prostaglandin Analogues - MDN, IPCP and DDDE
Date of publication: 6 June 2025
The SCCS has concluded that none of the three prostaglandin analogues evaluated can be considered safe for use in eyelash and eyebrow cosmetic products, citing potent pharmacological activity and lack of adequate reproductive/developmental toxicity data.
Ingredient: Methyl Salicylate
Date of publication: 2 May 2025
The SCCS has revised its scientific advice on children's exposure to Methyl Salicylate, establishing more restrictive concentration limits of 0.4% in toothpaste and 0.02% in other products for children aged 0-3 years, following aggregate exposure considerations from related salicylate assessments.
Ingredient: DHHB
Date of publication: 14/02/2025
On February 14, 2025, the Scientific Committee on Consumer Safety (SCCS) adopted its scientific advice on the safety of Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) used as a UV-filter in cosmetic products. The deadline for comments is set to April 25, 2025.
Ingredient: BHT
Date of publication: 24/02/2025
The February 24, 2025 implementation date for the UK's new restrictions on Butylated Hydroxytoluene (BHT) has now passed, with cosmetic companies required to comply with stricter limits, particularly for oral care products.
Ingredient: CYCLAMEN ALDEHYDE
Date of publication: 8 June 2026
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: OMNIBUS ACT IX - COSMETICS REGULATION
Date of publication: 28 July 2026
The European Commission notified the WTO about the draft Omnibus Act IX, proposing amendments to Annexes II, III, and V of the EU Cosmetics Regulation.
Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS
Date of publication: 13 January 2026
The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).
Ingredient: TALC
Date of publication: January 2026
The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.
A non-EU manufacturer needs an EU Authorised Representative; every manufacturer needs a PRRC. What each must do under the MDR, and what EUDAMED adds from 27 November 2026.
Class IIa, IIb and III devices need a periodic safety update report. How often, how to group devices, and where it goes while EUDAMED's vigilance module is pending.
Once software qualifies as a medical device, Rule 11 of MDR Annex VIII decides its class. How the rule works, and why so little software stays in class I.
A substantial change to an IVDR performance study must be notified within one week and cannot start for 38 days. Why the MDCG 2022-20 template still applies while EUDAMED's module is pending.
One email when an area publishes, in the language you choose. Nothing else.
